![]() |
|
Trainers and Research Areas
Joseph Bryant, DVM, Assoc. Prof. and Division Director; Development of animal models for cancer, AIDS, and neuropathological diseases. This includes transgenic and knockout mice (as well as a recent rat model), antibody production, and the use of non-human primate models. Division of Basic Science and Vaccine Research Robert Gallo, MD, Professor, IHV Director and Division Co-Director of the IHV; Discovery and characterization of naturally occurring inhibitors of HIV infection and Kaposi's Sarcoma. Role of HIV Tat in AIDS pathogenesis. Therapeutic approaches to AIDS. George Lewis, PhD, Professor and Division Co-Director; Correlates of immunity in AIDS vaccine development. Immunogenicity of lentvirus envelope proteins. Mechanisms of virus entry and neutralization. Anthony DeVico, PhD, Asst. Prof.; AIDS vaccines using gp120:CD4 complexes. Chemokines and other peptides in AIDS therapy. Alfredo Garzino-Demo, PhD, Asst. Prof.; Mutational alteration of chemokines to assess their role in AIDS. Roberta Kamin-Lewis, PhD, Res Asst. Prof.; Regulation of T-cell activation. Pathways of T-cell infection by HIV. HIV vaccine development. C. David Pauza, PhD, Professor; Therapeutic and prevention strategies against HIV and AIDS. Immunization against Tat protein. Manipulation of gd T lymphocyte responses. Development of attenuated viral vaccines expressing immunoregulatory molecules. Mikulas Popovic, MD, PhD, Professor; Relation of HIV chemokine-sensitivity to disease. Association of HIV isolates with neuropathology. Isolation of novel viruses. Marvin Reitz, PhD, Professor; HHV-8 and Kaposi's sarcoma (KS). KS-related oncogene expression. Chemokines and other factors capable of inhibiting HIV expression. Maria Salvato, PhD, Professor; Role of anti-apoptotic agents in AIDS therapy. Pathogenesis of hemorrhagic arenavirus. Arenavirus reverse genetics. Davide Zella, PhD, Visiting Scientist; Role of HIV Tat on signal transduction and cyto/chemokine induction. Molecular basis of Interferon -a immunosuppression. Division of Clinical Care and Research Robert Redfield, MD, Professor and Division Director; Clinical trials of antiviral agents for AIDS. Efficacy testing of therapeutic vaccines. Defining correlates of immunity and markers of disease progression. Carla Alexander, MD, Asst. Prof.; Palliative care and instruction for patients with multiple social risk factors and/or non-adherence. Special interest in underserved populations. Anthony Amoroso, MD, Asst. Prof.; HIV clinical trials. Structured treatment interruptions and interaction of antiviral agents with cell cycle status. Charles Davis, MD, Asst. Prof.; Director of the Clinical Trials Program of the Clinical Division. Particular interest in cell cycle manipulation in HIV therapy. Lori Fantry, MD, Asst. Prof.; Director of the Evelyn Jordan Clinic, the outpatient arm of the IHV clinical effort. Clinical trials in HIV care. Bruce Gilliam, MD, Asst. Prof.; HIV vaccine trials. David Oldach, MD, Assoc. Prof; Chronic viral infections in immunocompromised hosts; especially HCV in HIV infected individuals and in organ transplant recipients. Additional interest in environmental microbiology, in particular, the toxin-producing dinoflagellate Pfisteria piscida. Daniel Wolde Rufael, MD, Asst. Prof.; Hepatitis C/HIV co-infections. HIV clinical trials. Nick Stamatos, MD, PhD, Asst. Prof.; Neuraminidase and the role of sialic acid in viral-cell interactions. Division of Epidemiology and Prevention William A. Blattner, MD, Professor and Division Director; Studies on HIV pathogenesis and epidemiology in specific populations in the Caribbean and in Baltimore, MD. HIV vaccine trials research, including implementation, cohort development, and risk assessment. Alash'le Abimiku, PhD, Asst. Prof.; Characterization of Nigerian HIV isolates. Organizaton of vaccine trials in Nigeria. Niel Constantine, PhD, MT, Prof., Dept. of Pathology; Head of viral diagnostic lab: for HIV, hepatitis, herpes, HTLV, spirochete, and prion infections. Studies of epidemiologic prevalence and incidence of these infections in Europe, Africa, Asia, and Baltimore. IHV Postdoctoral Fellowship Application Download the Postdoctoral Fellowship Application (10KB, 4 pgs.)
|
![]() ![]() ![]() ![]() |
The Institute of Human Virology
725 West Lombard Street Baltimore, Maryland 21201 USA Office: 410-706-8614 Fax: 410-706-1952 |